Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Age, estrogen, and bone density

R J Worley

    Clinical Obstetrics and Gynecology
    |March 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Estrogen replacement therapy can significantly slow bone loss and reduce fracture risk in women with hypogonadism and osteoporosis. Benefits likely outweigh risks, especially with added progestin, alongside diet and exercise.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Refrigerated storage of Ham's F10 culture medium in assisted reproduction programs.

    Journal of assisted reproduction and genetics·1995
    Same author

    Hydropneumothorax after retrieval of oocytes.

    Southern medical journal·1990
    Same author

    Control of vascular reactivity in pregnancy.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·1987
    Same author

    Dysfunctional uterine bleeding. Clarifying its definition, mechanisms, and management.

    Postgraduate medicine·1986
    Same author

    Application of simplified laser laparoscopy to preparation of the pelvis for in vitro fertilization.

    The Journal of reproductive medicine·1985
    Same author

    Pathophysiology of pregnancy-induced hypertension.

    Clinical obstetrics and gynecology·1984
    Same journal

    Obstetric Care for Patients With Cognitive Disabilities.

    Clinical obstetrics and gynecology·2026
    Same journal

    Dissecting the Americans With Disabilities Act (ADA) Requirements when Approaching Obstetric Patients With Disabilities: How to Ensure Your Spaces are Accessible for All.

    Clinical obstetrics and gynecology·2026
    Same journal

    Clinician Comfort and Barriers to the Obstetric and Gynecologic Care of Patients With Disabilities.

    Clinical obstetrics and gynecology·2026
    Same journal

    Obstetric Care for Patients With Visual Impairments: Preconception Counseling Through Postpartum Care.

    Clinical obstetrics and gynecology·2026
    Same journal

    Menstrual Management and Contraception for Patients With Disabilities.

    Clinical obstetrics and gynecology·2026
    Same journal

    Favoring Elective Hospitalization in Pregnancies With Vasa Previa.

    Clinical obstetrics and gynecology·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Geriatrics
    • Bone Health

    Background:

    • Osteoporosis is a significant health issue in hypogonadal women, leading to morbidity, mortality, and high healthcare costs.
    • Estrogen deficiency accelerates bone loss and increases osteoporosis incidence in aging women.

    Purpose of the Study:

    • To evaluate the role of estrogen replacement therapy (ERT) in managing osteoporosis in hypogonadal women.
    • To assess the benefits and risks of ERT in preventing bone mineral loss and fractures.

    Main Methods:

    • Review of existing literature on estrogen therapy, bone mineral density, and fracture incidence in hypogonadal women.
    • Consideration of adjunctive therapies such as progestin, diet, physical activity, and calcium supplementation.

    Related Experiment Videos

    Main Results:

    • Estrogen therapy can substantially slow the rapid loss of bone mineral mass in aging women.
    • Estrogen therapy likely decreases the incidence of disabling fractures in elderly women.
    • The benefits of ERT for women at high risk for osteoporosis likely outweigh the risks, particularly when combined with a progestin.

    Conclusions:

    • Estrogen replacement therapy is a viable option for managing osteoporosis in hypogonadal women.
    • Optimal diet and physical activity are recommended for postmenopausal women.
    • Calcium supplementation and/or ERT are recommended for high-risk individuals.
    • Combined therapy with estrogen and progestin may offer a favorable risk-benefit profile.